Bayer – Combination Aspirin

A class action was filed against Bayer for marketing its Women’s Low-Dose Aspirin plus Calcium and its Aspirin with Heart Advantage without FDA approval.  The lawsuit also alleged that Bayer’s combination aspirin products could not provide all the advertised health benefits and were not suitable for long-term use.  In October 2012, Bayer agreed to pay $15 million to resolve the case. (In re: Bayer Corp. Combination Aspirin Products Marketing & Sales Practices Litigation, Case No. 1:2009md02023)


Print Friendly, PDF & Email

Tags: ,

Leave a Reply

Back to Top ↑
  • Search Class-Action Tracker

  • Recent Class Actions

  • The Class-Action Tracker is intended to notify consumers about false advertising class-action lawsuits filed around the country, but does not necessarily reflect’s opinion with respect to the lawsuits or disposition of the cases

  • Sign Up for E-mail Updates